In a rapidly evolving healthcare landscape, the need for smarter, faster, and more scalable pharmacovigilance (PV) solutions has never been greater. In a recent interview with Pharmaceutical Executive, Vikram Anand shares how EVERSANA is meeting this challenge head-on with the launch of EVERSANA ORCHESTRATE™ PV—a bold, AI-powered platform designed to simplify and accelerate drug safety operations.
From automating literature monitoring to enhancing global submission accuracy, the article explores how modern PV solutions are not only reducing operational burdens but also elevating safety outcomes across geographies.
This transformation is more than just technology—it’s about rethinking how we approach safety, compliance and efficiency in a rapidly evolving landscape. Vikram’s insights offer a glimpse into the future of pharmacovigilance, where innovation meets impact.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…